Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Authors:
Top Cited Papers
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807Journal of Alzheimer’s Disease, 2013
- Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)Journal of Molecular Neuroscience, 2011
- Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologiesJournal of Neurochemistry, 2009
- Longitudinal, Quantitative Assessment of Amyloid, Neuroinflammation, and Anti-Amyloid Treatment in a Living Mouse Model of Alzheimer's Disease Enabled by Positron Emission TomographyThe Journal of Neuroscience, 2007
- A New Take on TauScience, 2007
- 2-(2-[2-Dimethylaminothiazol-5-yl]Ethenyl)-6- (2-[Fluoro]Ethoxy)Benzoxazole: A Novel PET Agent for In Vivo Detection of Dense Amyloid Plaques in Alzheimer's Disease PatientsJournal of Nuclear Medicine, 2007
- PET of Brain Amyloid and Tau in Mild Cognitive ImpairmentNew England Journal of Medicine, 2006
- Two-year follow-up of amyloid deposition in patients with Alzheimer's diseaseBrain, 2006
- Quinoline and Benzimidazole Derivatives: Candidate Probes forIn VivoImaging of Tau Pathology in Alzheimer's DiseaseJournal of Neuroscience, 2005
- The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid ComponentJournal of Neuroscience, 2003